The Journal of Immunology, Vol 144, Issue 1 84-93, Copyright © 1990 by American Association of Immunologists

ARTICLES

Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production

GR Klimpel, CR Annable, MG Cleveland, TR Jerrells and JC Patterson
Department of Microbiology, University of Texas Medical Branch, Galveston 77550.

We have previously shown that both IFN-gamma and IFN-beta are produced in vivo and in vitro by spleen cells obtained from mice experiencing a chronic form of graft vs host disease (GVHD). Further, we have shown that in vitro production of IFN-beta by spleen cells from GVHD mice may play a role in the suppressed in vitro mitogen responsiveness of these cells. This study was undertaken to investigate if treatment of such mice with mAb to IFN-gamma or IFN-beta could alter the immunosuppression or lymphoid hypoplasia associated with chronic GVHD. GVHD was induced across minor histocompatibilities by the i.v. injection of B10.D2 spleen cells into sublethally irradiated BALB/c mice. These mice were given daily injections for 20 days of one of the following: 1) mAb to IFN-gamma, 2) mAb to IFN-beta, or 3) control IgG. Histologic examination of these mice at 21 to 22 days post transplantation revealed that mice treated with mAb to IFN-beta or control IgG had dramatic hypoplasia of the thymus, spleen, and lymph nodes which was similar to untreated GVHD mice. Mice given mAb to IFN- gamma, however, had no lymphoid hypoplasia and had a near normal gross and histologic appearance of their thymus, spleen, and lymph node tissue when compared with syngeneic controls. In vitro mitogen-induced proliferative responses of spleen and lymph node cells obtained from GVHD mice or GVHD mice treated with mAb to IFN-beta were severely suppressed or absent. In contrast, spleen and lymph node cells from GVHD mice given mAb to IFN-gamma were capable of giving a significant in vitro proliferative response to Con A, PHA, and LPS. Further, natural suppressor cell activity and spontaneous production of IFN- beta, a characteristic of this form of GVHD, was absent in spleen cells obtained from GVHD mice treated with mAb to IFN-gamma. These results further identify the IFN as playing critical roles in the pathogenesis of GVHD.

This article has been cited by other articles:

				Y.-G. Yang, J. Qi, M.-G. Wang, and M. Sykes Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells Blood, May 13, 2002; 99(11): 4207 - 4215. [Abstract] [Full Text] [PDF]

				S. E. J. Kaal, F. H. J. Van den Hoogen, E. M. G. J. De Jong, and H. E. Viëtor Systemic Sclerosis: New Insights in Autoimmunity Experimental Biology and Medicine, October 2, 1999; 222(1): 1 - 8. [Abstract] [Full Text]

				Y.-G. Yang, J. J. Sergio, D. A. Pearson, G. L. Szot, A. Shimizu, and M. Sykes Interleukin-12 Preserves the Graft-Versus-Leukemia Effect of Allogeneic CD8 T Cells While Inhibiting CD4-Dependent Graft-Versus-Host Disease in Mice Blood, December 1, 1997; 90(11): 4651 - 4660. [Abstract] [Full Text] [PDF]

				M. B. Baker, R. L. Riley, E. R. Podack, and R. B. Levy Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function PNAS, February 18, 1997; 94(4): 1366 - 1371. [Abstract] [Full Text] [PDF]

				J. Ferrara, K. Cooke, L Pan, and W Krenger The immunopathophysiology of acute graft-versus-host-disease Stem Cells, September 1, 1996; 14(5): 473 - 489. [Abstract]